Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001885 · ClinicalTrials.gov registry record

Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis

A clinical trial of Healthy and Rheumatoid Arthritis, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
400
Enrollment target
1
Study location

NCT00001885 is a study of Healthy and Rheumatoid Arthritis that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 400 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001885, a study of Healthy and Rheumatoid Arthritis, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Data gathered from previous research studies suggest that genetics may play a role in the development of PF in patients with rheumatoid arthritis. However, the actual genetic factors involved in the disease process have not been identified. The goal of this study is to identify the genetic markers in patients with pulmonary fibrosis and rheumatoid arthritis.

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 1999-03-21
Est. Completion 2007-12-28

What the Registry Record Tells You About NCT00001885

The ClinicalTrials.gov registry entry for NCT00001885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (38% lower). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT00001885 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00001885 about?

NCT00001885 is a clinical study titled "Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis". Pulmonary fibrosis (PF) is a condition in which the lungs of a patient become scarred and fibrous. It has been known to occur in as many as 40% of patients diagnosed with rheumatoid arthritis (RA). The cause of the pulmonary fibrosis in patients with RA is unknown. Data gathered from previous resea...

What is the current status of trial NCT00001885?

This trial is currently completed. The enrollment target is 400 participants. The study started on 1999-03-21. Estimated completion is 2007-12-28.

What conditions does trial NCT00001885 study?

This clinical trial studies the following conditions: Healthy, Rheumatoid Arthritis, Pulmonary Fibrosis.

Who is sponsoring clinical trial NCT00001885?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00001885 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.